MPT Product Development Database

This database includes MPT products that are currently in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Please note there are other MPT candidates not listed that may move forward pending funding. Click here to learn more about the inclusion criteria and information update methodology.
Click on the table for MPT products in the development pipeline by indication combination.
Know of an MPT product not included in this database or have updated information for listed products? Let us know here!
Hormonal/Non-HormonalDelivery RouteDelivery MethodDevelopment Stage
       
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
       
Key Word Search   
       

31 product(s) found

Results: 24 product(s) found
90-day Pod-type Etonogestrel/Ethinyl Estradiol/QGriffithsin (QGRFT) Intravaginal Ring [EEQ IVR]
MPT in Development
Hormonal Topical Intravaginal Ring (IVR)
  • Etonogestrel
  • Ethinyl Estradiol
  • QGriffithsin (QGRFT)
  • Oak Crest Institute of Science
  • Population Council
  • Pre1
  • HIV
  • Pregnancy
  • Amphora fast-dissolving vaginal insert (FDI)
    MPT in Development
    Non-Hormonal Topical Fast Dissolve Insert/Capsule-Vaginal
  • Citric Acid
  • L-lactic Acid
  • Potassium Bitartrate
  • Evofem Biosciences, Inc.
  • Population Council
  • Pre1
  • Bacterial Vaginosis (BV)
  • Chlamydia
  • Gonorrhea
  • Pregnancy
  • Amphora Gel
    MPT in Development
    Non-Hormonal Topical Gel-Vaginal
  • Citric Acid
  • L-lactic Acid
  • Potassium Bitartrate
  • Evofem Biosciences, Inc.
  • C3
  • Chlamydia
  • Gonorrhea
  • Pregnancy
  • Amphora/QGriffithsin (QGRFT) fast-dissolving vaginal insert (FDI)
    MPT in Development
    Non-Hormonal Topical Fast Dissolve Insert/Capsule-Vaginal
  • Citric Acid
  • L-lactic Acid
  • Potassium Bitartrate
  • QGriffithsin (QGRFT)
  • Evofem Biosciences, Inc.
  • Population Council
  • Pre1
  • Bacterial Vaginosis (BV)
  • Chlamydia
  • Gonorrhea
  • HIV
  • Pregnancy
  • Copper Intravaginal Ring (Cu-IVR)
    MPT in Development
    Non-Hormonal Topical Intravaginal Ring (IVR)
  • Copper
  • University of California, Davis
  • Pre1
  • HSV-2
  • Pregnancy
  • Zika virus (ZIKV)
  • Dapivirine + Levonorgestrel IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Dapivirine
  • Levonorgestrel
  • International Partnership for Microbicides (IPM)
  • C1
  • HIV
  • Pregnancy
  • Dapivirine + Pritelivir + Levonorgestrel 3D Printed IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Dapivirine
  • Levonorgestrel
  • Pritelivir
  • University of North Carolina, Chapel Hill
  • Pre1
  • HIV
  • HSV-2
  • Pregnancy
  • Dolutegravir (DTG) + Rilpivirine (RPV) + Acyclovir + Ethinyl Estradiol + Etonogestrel IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Dolutegravir
  • Etonogestrel
  • Ethinyl Estradiol
  • Rilpivirine
  • Auritec Pharmaceuticals
  • Pre2
  • HIV
  • HSV-2
  • Pregnancy
  • Dual Prevention Pill (DPP) Regimen
    MPT in Development
    Hormonal Systemic Pill/Tablet- Oral
  • Combined Oral Contraceptive (COC)
  • Emtricitabine (FTC)
  • Ethinyl Estradiol (EE)
  • Levonorgestrel
  • Tenofovir Disoproxil Fumarate (TDF)
  • Population Council
  • C4
  • HIV
  • Pregnancy
  • EFdA-P + Progestin Intravaginal Film
    MPT in Development
    Hormonal Topical Film - Vaginal
  • 4'-Ethynyl-2-fluoro-2'-deoxyadenosine prodrug (EFdA-P)
  • Progestin
  • Magee-Women's Research Inst. & Foundation
  • Pre1
  • HIV
  • Pregnancy
  • Griffithsin Gel
    MPT in Development
    Non-Contraceptive Topical Gel-Rectal
  • Griffithsin (GRFT)
  • University of Louisville
  • Pre1
  • Hepatitis
  • HIV
  • HSV-2
  • HCA + VRC01 + N6 IVR
    MPT in Development
    Non-Hormonal Topical Intravaginal Ring (IVR)
  • HCA
  • Monoclonal Antibodies
  • VRC01 + N6
  • MUCOMMUNE LLC
  • Pre2
  • HIV
  • Pregnancy
  • Islatravir (EFdA) + Etonogestrel/Ethinyl Estradiol 3D Printed IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Etonogestrel
  • Ethinyl Estradiol
  • Islatravir (EFdA)
  • University of North Carolina, Chapel Hill
  • Pre1
  • HIV
  • Pregnancy
  • mAb 2C7 + TDF IVR
    MPT in Development
    Non-Contraceptive Topical Intravaginal Ring (IVR)
  • Monoclonal Antibodies
  • Tenofovir Disoproxil Fumarate (TDF)
  • MassBiologics
  • Oak Crest Institute of Science
  • Planet Biotechnology, Inc.
  • University of Massachusetts
  • Pre2
  • Gonorrhea
  • HIV
  • MB66 Film
    MPT in Development
    Non-Contraceptive Topical Film - Vaginal
  • Monoclonal Antibodies
  • Mapp Biopharmaceutical, Inc.
  • C1
  • HIV
  • HSV-2
  • MIV-150 and zinc acetate in carrageenan gel (PC-1005)
    MPT in Development
    Non-Contraceptive Topical Gel-Vaginal;Rectal
  • Carrageenan
  • MIV-150
  • Zinc Acetate
  • Population Council
  • C2
  • HIV
  • HPV
  • HSV-2
  • MPT Microarray Patch (MAP)
    MPT in Development
    Hormonal Systemic Microarray Patch
  • Cabotegravir
  • Norelgestromin
  • PATH
  • Pre1
  • HIV
  • Pregnancy
  • Novel mAb contraceptive + TDF IVR
    MPT in Development
    Non-Hormonal Topical Intravaginal Ring (IVR)
  • Monoclonal Antibodies
  • Tenofovir Disoproxil Fumarate (TDF)
  • Oak Crest Institute of Science
  • University of North Carolina, Chapel Hill
  • Pre1
  • HIV
  • Pregnancy
  • Subcutaneous Contraceptive and HIV Implant Engineered for Long-Acting Delivery (SCHIELD) device
    MPT in Development
    Hormonal Systemic Implant (Subcutaneous)
  • Unspecified
  • Research Triangle International (RTI)
  • Pre1
  • HIV
  • Pregnancy
  • TAF / Elvitegravir Topical Insert
    MPT in Development
    Non-Contraceptive Topical Fast Dissolve Insert – Vaginal, Rectal
  • Elvitegravir
  • Tenofovir Alafenamide (TAF)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • Tenofovir + Levonorgestrel IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Levonorgestrel
  • Tenofovir (TFV)
  • CONRAD
  • C2
  • HIV
  • HSV-2
  • Pregnancy
  • Tenofovir IVR
    MPT in Development
    Non-Contraceptive Topical Intravaginal Ring (IVR)
  • Tenofovir (TFV)
  • CONRAD
  • C2
  • HIV
  • HSV-2
  • VivaGel® Vaginal Gel
    MPT in Development
    Non-Contraceptive Topical Gel-Vaginal
  • SPL7013 (Astodrimer Sodium)
  • Starpharma Pty Limited
  • Pre2
  • Bacterial Vaginosis (BV)
  • HIV
  • HPV
  • HSV-2
  • Yaso-GEL
    MPT in Development
    Non-Hormonal Topical Gel-Vaginal
  • Polyphenylene Carboxymethylene (PPCM)
  • Yaso Therapeutics
  • Pre2
  • Chlamydia
  • Gonorrhea
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • IMPT Secretariat
    1750 Howe Avenue, Suite 550
    Sacramento, CA 95825
    IMPT@cami-health.org

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated to advancing the comprehensive sexual and reproductive health of women and girls worldwide. CAMI Health is housed at the Public Health Institute (PHI).

    © Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.